PTC Therapeutics Inc (PTCT)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Stuart W. Peltz
Employees:
1,170
100 CORPORATE COURT, SOUTH PLAINFIELD, NJ 07080-2449
9082227000

PTC Therapeutics focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States; Tegsedi and Waylivra for the. treatment of rare diseases in Latin America and the Caribbean. PTC518 is being developed for Huntington's disease.

Data derived from most recent annual or quarterly report
Market Cap 3.3 Billion Shares Outstanding71.36 Million Avg 30-day Volume 880.402 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.89
Price to Revenue5.1636 Debt to Equity-1.2461 EBITDA-333.921 Million
Price to Book Value0.0 Operating Margin-47.629599999999996 Enterprise Value3.591 Billion
Current Ratio1.231 EPS Growth-0.24 Quick Ratio0.983
1 Yr BETA 0.8476 52-week High/Low 55.58 / 25.01 Profit Margin-76.2816
Operating Cash Flow Growth-5.1337 Altman Z-Score-1.432 Free Cash Flow to Firm -331.726 Million
Earnings Report2023-02-21
View SEC Filings from PTCT instead.

View recent insider trading info

Funds Holding PTCT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PTCT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-18:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-07:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-15:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-21:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    20.7 Thousand total shares from 31 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PAUWELS ERIC CHIEF BUSINESS OFFICER

    • Officer
    65,912 2023-01-24 6

    ALMSTEAD NEIL GREGORY CHIEF TECHNICAL OPS OFFICER

    • Officer
    3,287 2023-01-24 5

    PELTZ STUART WALTER CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    55,204 2023-01-24 7

    HILL EMILY LUISA CHIEF FINANCIAL OFFICER

    • Officer
    46,863 2023-01-24 6

    BOULDING MARK ELLIOTT EXEC. VP AND CLO

    • Officer
    76,190 2023-01-10 9

    UTTER CHRISTINE MARIE SVP, FINANCE & CAO

    • Officer
    38,384 2023-01-10 4

    KLEIN MATTHEW B. CHIEF OPERATING OFFICER

    • Officer
    77,856 2023-01-10 4

    SOUTHWELL DAVID P

    • Director
    20,500 2023-01-05 1

    STEELE GLENN JR MD PHD

    • Director
    20,500 2023-01-05 1

    SCHMERTZLER MICHAEL

    • Director
    137,766 2023-01-05 1

    ZELDIS JEROME B

    • Director
    20,500 2023-01-05 1

    JACOBSON ALLAN STEVEN

    • Director
    22,348 2023-01-05 1

    REEVE EMMA

    • Director
    21,528 2023-01-05 1

    OKEY STEPHANIE

    • Director
    15,867 2023-01-05 2

    SMITH MARY L.

    • Director
    19,813 2023-01-05 1

    YOUNG ALETHIA

    • Director
    19,067 2023-01-05 3

    SVORONOS DAWN

    • Director
    29,017 2022-06-09 1

    SOUZA MARCIO CHIEF OPERATING OFFICER

    • Officer
    6,744 2020-02-10 0

    ROTHERA MARK CHIEF COMMERCIAL OFFICER

    • Officer
    42,955 2017-05-24 0

    KOVACS SHANE WILLIAM CHARLES CHIEF FINANCIAL OFFICER

    • Officer
    37,850 2017-05-09 0

    COMPLETE PHARMA HOLDINGS II, LLC

    • 10% Owner
    No longer subject to file 2017-04-28 0

    RENAUD RONALD C JR

    • Director
    0 2017-01-03 0

    KOPPEL ADAM

    • Director
    0 2017-01-03 0

    MCDONOUGH CAMERON GEOFFREY

    • Director
    0 2017-01-03 0

    ONG TUYEN CHIEF MEDICAL OFFICER

    • Officer
    6,000 2017-01-03 0

    SPIEGEL ROBERT J. CHIEF MEDICAL OFFICER

    • Officer
    0 2016-01-04 0

    ALDRICH RICHARD

    • Director
    No longer subject to file 2015-06-08 0

    KRANDA MICHAEL L

    • Director
    2,242 2015-03-16 0

    HIRAWAT CLAUDIA DE OLIVEIRA RIBEIRO PRESIDENT

    • Officer
    No longer subject to file 2015-01-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER by spouse

    2023-01-26 16:24:11 -0500 2023-01-24 S 284 $47.45 d 55,204 indirect

    PAUWELS ERIC - Officer CHIEF BUSINESS OFFICER

    2023-01-26 16:23:09 -0500 2023-01-24 S 359 $47.45 d 65,912 direct

    HILL EMILY LUISA - Officer CHIEF FINANCIAL OFFICER

    2023-01-26 16:21:33 -0500 2023-01-24 S 223 $47.45 d 46,863 direct

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER by spouse

    2023-01-26 16:20:37 -0500 2023-01-24 S 44 $47.45 d 3,287 indirect

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER by spouse

    2023-01-12 16:34:27 -0500 2023-01-11 S 492 $44.36 d 55,488 indirect 0.0 -0.9627 0.0 1 -2.6789 4

    PAUWELS ERIC - Officer CHIEF BUSINESS OFFICER

    2023-01-12 16:35:24 -0500 2023-01-11 S 571 $44.36 d 66,271 direct 0.0 -0.9627 0.0 1 -2.6789 4

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-01-12 16:34:27 -0500 2023-01-11 S 1,189 $44.36 d 169,282 direct 0.0 -0.9627 0.0 1 -2.6789 4

    KLEIN MATTHEW B. - Officer CHIEF OPERATING OFFICER

    2023-01-12 16:36:40 -0500 2023-01-11 S 2,244 $44.36 d 77,856 direct 0.0 -0.9627 0.0 1 -2.6789 4

    HILL EMILY LUISA - Officer CHIEF FINANCIAL OFFICER

    2023-01-12 16:37:53 -0500 2023-01-11 S 418 $44.36 d 47,086 direct 0.0 -0.9627 0.0 1 -2.6789 4

    BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

    2023-01-12 16:38:43 -0500 2023-01-11 S 495 $44.36 d 76,190 direct 0.0 -0.9627 0.0 1 -2.6789 4

    UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

    2023-01-12 16:33:27 -0500 2023-01-11 S 417 $44.36 d 38,384 direct 0.0 -0.9627 0.0 1 -2.6789 4

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER

    2023-01-12 16:39:29 -0500 2023-01-11 S 383 $44.36 d 64,579 direct 0.0 -0.9627 0.0 1 -2.6789 4

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER by spouse

    2023-01-12 16:39:29 -0500 2023-01-11 S 27 $44.36 d 3,331 indirect 0.0 -0.9627 0.0 1 -2.6789 4

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-01-12 16:34:27 -0500 2023-01-10 S 1,228 $42.93 d 170,471 direct 0.0 -0.9627 0.0 1 -2.6789 4

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER by spouse

    2023-01-12 16:34:27 -0500 2023-01-10 S 571 $42.93 d 55,980 indirect 0.0 -0.9627 0.0 1 -2.6789 4

    UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

    2023-01-12 16:33:27 -0500 2023-01-10 S 489 $42.93 d 38,801 direct 0.0 -0.9627 0.0 1 -2.6789 4

    PAUWELS ERIC - Officer CHIEF BUSINESS OFFICER

    2023-01-12 16:35:24 -0500 2023-01-10 S 663 $42.93 d 66,842 direct 0.0 -0.9627 0.0 1 -2.6789 4

    KLEIN MATTHEW B. - Officer CHIEF OPERATING OFFICER

    2023-01-12 16:36:40 -0500 2023-01-10 S 2,273 $42.93 d 80,100 direct 0.0 -0.9627 0.0 1 -2.6789 4

    HILL EMILY LUISA - Officer CHIEF FINANCIAL OFFICER

    2023-01-12 16:37:53 -0500 2023-01-10 S 497 $42.93 d 47,504 direct 0.0 -0.9627 0.0 1 -2.6789 4

    BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

    2023-01-12 16:38:43 -0500 2023-01-10 S 590 $42.93 d 76,685 direct 0.0 -0.9627 0.0 1 -2.6789 4

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER

    2023-01-12 16:39:29 -0500 2023-01-10 S 473 $42.93 d 64,962 direct 0.0 -0.9627 0.0 1 -2.6789 4

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER by spouse

    2023-01-12 16:39:29 -0500 2023-01-10 S 27 $42.93 d 3,358 indirect 0.0 -0.9627 0.0 1 -2.6789 4

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER by spouse

    2023-01-11 18:16:41 -0500 2023-01-09 S 43 $41.66 d 3,385 indirect -0.1045 -0.1882 0.0 1 -2.7807 5

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER

    2023-01-11 18:16:41 -0500 2023-01-09 S 716 $41.66 d 65,435 direct -0.1045 -0.1882 0.0 1 -2.7807 5

    HILL EMILY LUISA - Officer CHIEF FINANCIAL OFFICER

    2023-01-11 18:15:45 -0500 2023-01-09 S 758 $41.66 d 48,001 direct -0.1045 -0.1882 0.0 1 -2.7807 5

    BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

    2023-01-11 18:14:36 -0500 2023-01-09 S 835 $41.66 d 77,275 direct -0.1045 -0.1882 0.0 1 -2.7807 5

    KLEIN MATTHEW B. - Officer CHIEF OPERATING OFFICER

    2023-01-11 18:13:34 -0500 2023-01-09 S 731 $41.66 d 82,373 direct -0.1045 -0.1882 0.0 1 -2.7807 5

    PAUWELS ERIC - Officer CHIEF BUSINESS OFFICER

    2023-01-11 18:12:36 -0500 2023-01-09 S 858 $41.66 d 67,505 direct -0.1045 -0.1882 0.0 1 -2.7807 5

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER by spouse

    2023-01-11 18:11:31 -0500 2023-01-09 S 279 $41.66 d 56,551 indirect -0.1045 -0.1882 0.0 1 -2.7807 5

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-01-11 18:11:31 -0500 2023-01-09 S 1,786 $41.66 d 171,699 direct -0.1045 -0.1882 0.0 1 -2.7807 5

    UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

    2023-01-11 18:10:37 -0500 2023-01-09 S 706 $41.66 d 39,290 direct -0.1045 -0.1882 0.0 1 -2.7807 5

    UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

    2023-01-09 16:58:57 -0500 2023-01-05 A 14,000 a 39,996 direct 3.0658 6.4022 7.8224 3 0.0 1

    UTTER CHRISTINE MARIE - Officer SVP, FINANCE & CAO

    2023-01-09 16:58:57 -0500 2023-01-05 A 32,500 a 32,500 direct

    REEVE EMMA - Director

    2023-01-09 16:13:21 -0500 2023-01-05 A 4,000 a 11,528 direct 3.0658 6.4022 7.8224 3 0.0 1

    SCHMERTZLER MICHAEL - Director

    2023-01-09 16:27:05 -0500 2023-01-05 A 8,000 a 117,766 direct 3.0658 6.4022 7.8224 3 0.0 1

    JACOBSON ALLAN STEVEN - Director

    2023-01-09 16:17:02 -0500 2023-01-05 A 10,000 a 10,000 direct

    JACOBSON ALLAN STEVEN - Director

    2023-01-09 16:17:02 -0500 2023-01-05 A 4,000 a 12,348 direct 3.0658 6.4022 7.8224 3 0.0 1

    ZELDIS JEROME B - Director

    2023-01-09 16:16:13 -0500 2023-01-05 A 10,000 a 10,000 direct

    ZELDIS JEROME B - Director

    2023-01-09 16:16:13 -0500 2023-01-05 A 4,000 a 10,500 direct 3.0658 6.4022 7.8224 3 0.0 1

    YOUNG ALETHIA - Director

    2023-01-09 16:14:23 -0500 2023-01-05 A 10,000 a 10,000 direct

    YOUNG ALETHIA - Director

    2023-01-09 16:14:23 -0500 2023-01-05 A 4,000 a 9,067 direct 3.0658 6.4022 7.8224 3 0.0 1

    REEVE EMMA - Director

    2023-01-09 16:13:21 -0500 2023-01-05 A 10,000 a 10,000 direct

    SCHMERTZLER MICHAEL - Director

    2023-01-09 16:27:05 -0500 2023-01-05 A 20,000 a 20,000 direct

    STEELE GLENN JR MD PHD - Director

    2023-01-09 16:12:26 -0500 2023-01-05 A 10,000 a 10,000 direct

    STEELE GLENN JR MD PHD - Director

    2023-01-09 16:12:26 -0500 2023-01-05 A 4,000 a 10,500 direct 3.0658 6.4022 7.8224 3 0.0 1

    SOUTHWELL DAVID P - Director

    2023-01-09 16:10:22 -0500 2023-01-05 A 10,000 a 10,000 direct

    SOUTHWELL DAVID P - Director

    2023-01-09 16:10:22 -0500 2023-01-05 A 4,000 a 10,500 direct 3.0658 6.4022 7.8224 3 0.0 1

    SMITH MARY L. - Director

    2023-01-09 16:09:16 -0500 2023-01-05 A 10,000 a 10,000 direct

    SMITH MARY L. - Director

    2023-01-09 16:09:16 -0500 2023-01-05 A 4,000 a 9,813 direct 3.0658 6.4022 7.8224 3 0.0 1

    OKEY STEPHANIE - Director

    2023-01-09 16:08:13 -0500 2023-01-05 A 10,000 a 10,000 direct

    OKEY STEPHANIE - Director

    2023-01-09 16:08:13 -0500 2023-01-05 A 4,000 a 5,867 direct 3.0658 6.4022 7.8224 3 0.0 1

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-01-09 16:51:56 -0500 2023-01-05 A 53,000 a 173,485 direct 3.0658 6.4022 7.8224 3 0.0 1

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER by spouse

    2023-01-09 16:51:56 -0500 2023-01-05 A 18,000 a 56,830 indirect 3.0658 6.4022 7.8224 3 0.0 1

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-01-09 16:51:56 -0500 2023-01-05 A 132,500 a 132,500 direct

    PELTZ STUART WALTER - Director - Officer CHIEF EXECUTIVE OFFICER by spouse

    2023-01-09 16:51:56 -0500 2023-01-05 A 45,000 a 45,000 indirect

    KLEIN MATTHEW B. - Officer CHIEF OPERATING OFFICER

    2023-01-09 16:52:57 -0500 2023-01-05 A 26,000 a 83,104 direct 3.0658 6.4022 7.8224 3 0.0 1

    KLEIN MATTHEW B. - Officer CHIEF OPERATING OFFICER

    2023-01-09 16:52:57 -0500 2023-01-05 A 65,000 a 65,000 direct

    PAUWELS ERIC - Officer CHIEF BUSINESS OFFICER

    2023-01-09 16:54:12 -0500 2023-01-05 A 18,000 a 68,363 direct 3.0658 6.4022 7.8224 3 0.0 1

    PAUWELS ERIC - Officer CHIEF BUSINESS OFFICER

    2023-01-09 16:54:12 -0500 2023-01-05 A 45,000 a 45,000 direct

    HILL EMILY LUISA - Officer CHIEF FINANCIAL OFFICER

    2023-01-09 16:55:35 -0500 2023-01-05 A 19,500 a 48,759 direct 3.0658 6.4022 7.8224 3 0.0 1

    HILL EMILY LUISA - Officer CHIEF FINANCIAL OFFICER

    2023-01-09 16:55:35 -0500 2023-01-05 A 42,500 a 42,500 direct

    BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

    2023-01-09 16:56:46 -0500 2023-01-05 A 17,000 a 78,110 direct 3.0658 6.4022 7.8224 3 0.0 1

    BOULDING MARK ELLIOTT - Officer EXEC. VP AND CLO

    2023-01-09 16:56:46 -0500 2023-01-05 A 36,250 a 36,250 direct

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER

    2023-01-09 16:58:00 -0500 2023-01-05 A 17,000 a 66,151 direct 3.0658 6.4022 7.8224 3 0.0 1

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER by spouse

    2023-01-09 16:58:00 -0500 2023-01-05 A 710 a 3,428 indirect 3.0658 6.4022 7.8224 3 0.0 1

    ALMSTEAD NEIL GREGORY - Officer CHIEF TECHNICAL OPS OFFICER

    2023-01-09 16:58:00 -0500 2023-01-05 A 36,250 a 36,250 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    PTC THERAPEUTICS INC PTCT 2023-01-27 22:15:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 21:45:04 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 21:15:04 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 20:45:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 20:15:04 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 19:45:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 19:15:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 18:45:04 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 18:15:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 17:45:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 17:15:04 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 16:45:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 16:15:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 15:45:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 15:15:04 UTC 4.07 0.25 950000
    PTC THERAPEUTICS INC PTCT 2023-01-27 14:45:04 UTC 4.07 0.25 950000
    PTC THERAPEUTICS INC PTCT 2023-01-27 14:15:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 13:45:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 13:15:03 UTC 4.07 0.25 1000000
    PTC THERAPEUTICS INC PTCT 2023-01-27 12:45:03 UTC 4.07 0.25 1000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund PTCT -491.0 shares, $-23582.73 2019-12-31 N-PORT
    FundVantage Trust- Gotham Enhanced Index Plus Fund PTCT -19.0 shares, $-847.59 2020-03-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund PTCT -143.0 shares, $-6685.25 2020-09-30 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund PTCT -47.0 shares, $-2096.67 2020-03-31 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund PTCT -509.0 shares, $-25551.8 2022-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments